期刊文献+

5′-去氧-5′-N-[3-(2-羟基苯)丙烯酰基]氨基腺苷的设计与合成

Design and synthesis of 5′-deoxy-5′-N-[3-(2-hydroxy)phenpropyleneacyl]aminoadenosine
下载PDF
导出
摘要 分枝杆菌生长素是结核分枝杆菌生长和毒性的关键性因素。MbtA酶是催化生物合成分枝杆菌生长素的关键性酶,现已成为新型抗结核药物研究的重要靶点。以水杨醛、嘌呤核苷为原料,经过麦克尔加成反应、羟醛缩合等一系列的反应,设计合成了新型核苷类标题化合物。目标化合物采用IR、MS、1HNMR和13CNMR测试技术对其结构进行了表征。 Mycobactins are the critical factors for the growth and virulence of M.tuberculosis.Biosynthesis of mycobactin begins with an adenylate-forming enzyme,MbtA,which has emerged as an attractive target for the development of anti-TB agents.A new compound 5′-deoxy-5′-N-[3-(2-hydroxy)phenpropyleneacyl] aminoadenosine,which was designed to be an inhibitor of MbtA,was synthesized from the starting materials salicylaldehyde and adenosine via a series of reactions such as the Michael addition and condensation reactions.The structure of the compound was determined by 1HNMR,13CNMR,IR and MS/ESI.The biological activity of this compound was also investigated.
作者 王蕾 乔春华
出处 《化学试剂》 CAS CSCD 北大核心 2010年第6期503-506,共4页 Chemical Reagents
关键词 MbtA 抗结核 设计 合成 核苷类化合物 MbtA anti-TB design synthesis nucleoside
  • 相关文献

参考文献8

  • 1汤光.抗结核药的现状和合理应用[J].临床药物治疗杂志,2003,1(3):1-2. 被引量:4
  • 2张致平.抗结核药物研究进展[J].中国抗生素杂志,2004,29(12):705-711. 被引量:16
  • 3FERRERAS J A,RYU J S,LELLO F D,et al. Small-molecule inhibition of siderophore biosynthesis in Mycobaeterium tuberculosis and Yersenia pestis[J]. Nature Chem. Biol. ,2005,1 (3) :29-32.
  • 4QIAO Chun-hua,WILSON D J,BENNETT E M,et al. A mechanism-based aryl carrier protein/thiolation domain affinity probe [ J ]. J. Am. Chem. Soc. , 2007,129 ( 12 ) : 6 350-6 351.
  • 5QIAO Chun-hua, GUPTE A, BOSHOFF H I, et al. 5'-O- [ (N-Acyl) sulfamoyl] adenosines as antitubercular agents that inhibit MbtA : an adenylation enzyme required for siderophore biosynthesis of the mycobactins [ J ]. J. Med. Chem. ,2007,50(9) :6 080-6 094.
  • 6SOMN R V,WILSON D J,BENETT E M,et al. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyldomain [ J ]. J. Med. Chem. , 2006,49(5) :7 623-7 635.
  • 7LIU Fei, AUSTIN D J. A general Synthesis of 5'-azido-5 '- deoxy-2', 3'-O-isopropylidene nucleosides [ J ]. J. Org. Chem. ,2001,66(7) :8 643-8 645.
  • 8SHEEHAN J C, LEDIS S L. Total synthesis of a monocyclic peptide lactone antibiotic [ J ]. J. Am. Chem. Soc., 1973,95(10) :875-879.

二级参考文献26

  • 1Global Alliance for TB Drug Development. Scientific blueprint for tuberculosis drug development [J]. Tuberculosis, 2001,81 (Suppl 1 ): 1
  • 2Igarashi M, Nakagawa N, Hattori S, et al. Caprazamycin A-F, novel anti-TB antibiotics from Streptomyces sp.[C]. Abstracts 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, ASM. Washigton,D.C. 2002:232
  • 3Ishikaw T, Benzo C. Phenathridine bases and their antibacterial activity [J]. Med Chem Rev, 2001,21: 61
  • 4Jarvis B, LambHM. Rifapentine [J]. Drugs,1998,56:607
  • 5Brogden R N, Fitton A, Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy [J]. Drugs. 1994,47: 983
  • 6Saito H, Tomioka H, Sato M, et al. In vitro antimycobacterial activity of newly synthesuzed benzoxazinorifamycins [J]. Antimicrob Agents Chemother, 1991 , 35: 542
  • 7Dietze R, Teixeira L, Rocha L M C, et al. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis [J]. Antimicrob Agents Chemother,2001,45:1972
  • 8Koletra S L, Berry A J, Cynamon M H, et al. Azithromycin as treatment for disseminated Mycobacrerium avium complex in AIDS patients [J]. Antimicrob Agents Chemother, 1999,43: 2867
  • 9Nilius A M, Bui M H, Almer L, et al. Comparative in vitro activity of ABT-773, a novel antibacterial ketolide [J]. Antimicrob Agents Chemother , 2001,45: 2168
  • 10Alvirez-Freites E J, Carter J L, Cynamon M H. In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis [J]. Antimicrob Agents Chemother,2002,46: 1022

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部